SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.248
EU - Europa 4.586
AS - Asia 2.844
SA - Sud America 27
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 1
Totale 29.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.201
CN - Cina 1.837
UA - Ucraina 1.380
DE - Germania 913
TR - Turchia 866
IT - Italia 725
GB - Regno Unito 645
SE - Svezia 320
FI - Finlandia 313
PL - Polonia 87
BE - Belgio 63
RU - Federazione Russa 51
FR - Francia 50
VN - Vietnam 49
CA - Canada 46
IN - India 23
IR - Iran 16
HK - Hong Kong 13
BR - Brasile 12
CL - Cile 11
JP - Giappone 11
AU - Australia 7
NZ - Nuova Zelanda 7
SG - Singapore 7
A2 - ???statistics.table.value.countryCode.A2??? 6
KR - Corea 6
AT - Austria 5
EU - Europa 5
NL - Olanda 4
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
IE - Irlanda 3
LU - Lussemburgo 3
RO - Romania 3
AR - Argentina 2
BG - Bulgaria 2
CH - Svizzera 2
IQ - Iraq 2
NO - Norvegia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 29.731
Salva come PNG Salva come JPEG
Città #
Fairfield 3.307
Woodbridge 2.890
Houston 1.957
Ashburn 1.614
Jacksonville 1.591
Ann Arbor 1.518
Chandler 1.392
Seattle 1.339
Wilmington 1.180
Cambridge 1.156
Izmir 546
Nanjing 454
Princeton 355
Beijing 350
Ferrara 281
San Diego 280
Boardman 241
New York 196
Milan 181
Shanghai 159
Nanchang 137
Shenyang 129
Dearborn 127
Falls Church 92
Warsaw 82
Hebei 81
San Mateo 81
Norwalk 78
Jiaxing 75
Bremen 74
Tianjin 74
Changsha 67
Redwood City 64
Mountain View 63
Brussels 61
Jinan 56
Addison 48
Auburn Hills 48
Dong Ket 45
London 43
Los Angeles 43
Munich 43
Kunming 42
Washington 42
Zhengzhou 41
Philadelphia 38
Mcallen 30
Guangzhou 29
Helsinki 29
Montréal 29
Tappahannock 28
Des Moines 27
Orange 27
Indiana 26
Ningbo 26
Fuzhou 20
Verona 20
Bologna 18
Lanzhou 18
Redmond 18
Leawood 17
Augusta 16
Hangzhou 14
Hounslow 12
Düsseldorf 10
Padova 10
Taizhou 10
Toronto 10
Ardabil 9
Changchun 8
Prescot 7
Walnut 7
Ferrara di Monte Baldo 6
Hefei 6
Hong Kong 6
Islington 6
Kilburn 6
San Francisco 6
Bari 5
Chiswick 5
Haikou 5
La Canada Flintridge 5
Monmouth Junction 5
Mumbai 5
Yellow Springs 5
Boston 4
Central District 4
Chicago 4
Edinburgh 4
Florence 4
Hanoi 4
Jena 4
Moscow 4
Singapore 4
Adelaide 3
Baltimore 3
Changping 3
Dallas 3
Dublin 3
Hyderabad 3
Totale 23.361
Salva come PNG Salva come JPEG
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 227
null 205
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 185
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 159
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 159
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 156
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 154
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 153
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 142
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 140
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 139
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 138
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 136
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 133
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 131
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 131
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 131
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 130
A new selective antagonist of the nociceptin receptor 130
Pharmacological characterization of nociceptin receptor: an in vitro study 130
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 129
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 128
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 128
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 128
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 128
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 127
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 127
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 126
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 126
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 125
A new ligand for the urotensin II receptor 124
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 124
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 123
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 123
Modulation of the NOP receptor signaling affects resilience to acute stress 122
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 121
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 121
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 120
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 120
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 120
Cardiovascular effects of nociceptin in unanesthetized mice 119
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 119
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 119
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 118
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 118
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 118
Effects of vasoactive agents in healthy and diseased human saphenous veins 118
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 118
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 118
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 117
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. 117
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 117
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 115
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 114
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 114
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 114
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 113
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 113
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 113
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 113
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 112
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 112
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 112
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 112
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 112
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 111
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 110
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 110
Actual concept of "probiotics": is it more functional to science or business? 110
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 110
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 110
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 110
null 110
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 109
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 108
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 107
Pharmacological characterization of tachykinin tetrabranched derivatives 107
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 106
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 106
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 106
Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex 106
Desensitisation of native and recombinant human urotensin-II receptors. 106
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 106
Sudden death from pulmonary thromboembolism: chronobiological aspects 105
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 105
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 105
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 105
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 105
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 105
Structure-activity study at positions 3 and 4 of human neuropeptide S. 105
null 105
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux 104
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 104
Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain 103
B1 and B2 kinin receptors in various species 103
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 103
null 103
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. 103
Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test 102
Totale 12.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.036
Totale 112.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.568 0 0 0 0 0 0 0 0 0 793 1.086 1.689
2019/20207.467 1.069 269 255 1.078 558 872 748 783 660 653 331 191
2020/20214.830 378 445 264 570 307 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.454 379 160 114 414 572 485 177 315 469 21 196 152
2023/20241.253 196 229 88 50 99 310 74 142 35 30 0 0
Totale 30.190